EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

Bayer poaches GlaxoSmithKline exec to lead expanding oncology business—including a blockbuster hopeful

Oncology is hardly what Bayer is known for. But the German drugmaker has raided GlaxoSmithKline—which is itself reestablishing a cancer foothold—for a new leader in t...
Continue Reading →
Regional News

J&J, plowing ahead with talc bankruptcy strategy, faces investor push to pull product worldwide

Johnson & Johnson has asked U.S. officials to cut in after an activist investor sought to halt sales of the company’s talc-based baby powder abroad. Separately, t...
Continue Reading →
Regional News

Amgen’s COVID-19 manufacturing deal with Lilly helped compensate for lagging Aimovig, Enbrel in Q4

As Amgen struggles to find growth from its own drugs, the company got a nice late-2021 revenue bump from its manufacturing partnership with Eli Lilly. Monday afterno...
Continue Reading →
Regional News

Novo Nordisk’s Wegovy passes NICE checkpoint on course to blockbusterland

Novo Nordisk’s new weight loss contender Wegovy passed another milestone on the road to blockbusterland, courtesy of a green light from England’s drug cost watchdog. ...
Continue Reading →
Regional News

How United Cargo is Connecting Lifesaving Pharma to Patients Across the Globe

Airfreight is proven to be the quickest way of transporting goods long distances – with speed and efficiency being the keys to success. With over one billion pounds o...
Continue Reading →
Regional News

As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn’t see virus going away for ‘foreseeable future’

Among all biopharma companies, Pfizer has had the most successful response to COVID-19 by bringing to market a hugely lucrative vaccine and a new antiviral pill. Desp...
Continue Reading →
Regional News

Teva survey finds COVID has ‘widened the chasm’ on health disparities

By now, it’s no surprise that the global pandemic has worsened long-standing health inequities—and pharma has stepped up with a flood of initiatives to try to tackle ...
Continue Reading →
Regional News

Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late?

It's finally here: After a series of delays in the lead-up to Novavax's COVID-19 vaccine filing with the FDA, the biotech has completed its emergency use authorizatio...
Continue Reading →
Regional News

CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say

Neurologists in the U.S. are agreeing with a new draft decision from the Centers for Medicare & Medicaid Services (CMS) that restricts reimbursement of Biogen’s c...
Continue Reading →
Regional News

GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing

Last January, when GlaxoSmithKline’s ViiV Healthcare won a long-awaited approval for its long-acting HIV treatment Cabenuva, it was hailed as a game-changer as it rem...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18